Clinical Trial Update: Cilengitide Imaging Trial in Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 imaging trial of cilengitide in supratentorial newly diagnosed inoperable glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Supratentorial Newly Diagnosed Inoperable Gliobastoma | Phase 1 | Status: TERMINATED